SRx Health Solutions Appoints Joshua Epstein to Board of Directors
ByAinvest
Monday, Oct 6, 2025 2:05 pm ET1min read
SRXH--
The press release, issued by SRx Health Solutions, Inc., states that Epstein's appointment is part of a straightforward addition to the company's governance structure. The announcement includes forward-looking statements, which are subject to the Private Securities Litigation Reform Act of 1995 [1]. These statements highlight the company's expectations about future events and financial trends, emphasizing that actual results may differ from projections.
The press release also includes standard contact information for further inquiries. Investors are advised to refer to the company's filings with the SEC for additional risk factors and forward-looking statements.
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
• SRx Health Solutions appoints Joshua Epstein to Board of Directors and Compensation Committee. • Epstein brings expertise in digital health and data analytics. • Forward-looking statements in press release. • Private Securities Litigation Reform Act of 1995 applies.
SRx Health Solutions (NYSE American: SRXH) has announced the appointment of Joshua Epstein to its Board of Directors and Compensation Committee. The announcement, made on October 1, 2025, reflects a strategic move to bolster the company's governance structure with Epstein's expertise in digital health and data analytics [1].The press release, issued by SRx Health Solutions, Inc., states that Epstein's appointment is part of a straightforward addition to the company's governance structure. The announcement includes forward-looking statements, which are subject to the Private Securities Litigation Reform Act of 1995 [1]. These statements highlight the company's expectations about future events and financial trends, emphasizing that actual results may differ from projections.
The press release also includes standard contact information for further inquiries. Investors are advised to refer to the company's filings with the SEC for additional risk factors and forward-looking statements.
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet